Article | August 20, 2026
FDA Proposes Mandatory GRAS Notification, but Stops Short of Premarket Approval
Read More
Article | August 11, 2026
OIG Reaffirms: Fair Market Value Alone Does Not Eliminate Anti-Kickback Statute Risk
Read More
Article | July 28, 2026
OIG Advisory Opinion 26‑11 Offers Guardrails for Free Diagnostic Reports
Read More
Article | July 22, 2026
FDA's Anticipated Proposed Rulemaking for Direct-to-Consumer Advertising
Read More
Article | July 21, 2026
Rebecca Zadaka and Paul Rothermel Named 2026 Super Lawyers Rising Stars
Read More
Article | July 07, 2026
CMS Launches New Office Focused on AI, Interoperability & Digital Health
Read More
Article | June 30, 2026
Vermont’s New Privacy Law Comes with Broad Consumer Health Data Requirements
Read More
Article | June 23, 2026
OIG Advisory Opinion 26‑10 Signals Scrutiny of Royalty‑Based HCP Consulting Arrangements
Read More
Article | June 16, 2026
FDA’s Drug Repurposing Initiative Signals a Shift in Regulatory Strategy
Read More
Article | June 12, 2026